Amgen Inc (AMGN)

Jan 17, 2025, 9:01 AM EST - 13 hours ago

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

Jan 16, 2025, 7:00 PM EST - 1 day ago

US FDA approves Amgen's colorectal cancer therapy

Jan 13, 2025, 8:36 PM EST - 4 days ago

Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AZN BNTX FBCG GILD GSK IBB

Jan 8, 2025, 4:01 PM EST - 9 days ago

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 8, 2025, 11:13 AM EST - 9 days ago

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

BBIO BMY IOVA LLY MDGL MRK PFE

Jan 8, 2025, 8:00 AM EST - 9 days ago

Asher Bio Announces Clinical Trial Collaboration and Supply Agreement on Etakafusp Alfa (AB248) in Combination with Bispecific T-cell Engager in Patients with Small Cell Lung Cancer

Jan 6, 2025, 7:30 AM EST - 11 days ago

Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)

Jan 6, 2025, 4:25 AM EST - 11 days ago

Amgen's IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom

Jan 5, 2025, 7:18 PM EST - 12 days ago

Amgen: Blockbusters, Emerging Therapies, And Investment Potential

Jan 4, 2025, 11:49 AM EST - 13 days ago

Big Blue Chip Dividends? Try These ‘Dogs' Up To 6.8%

CSCO CVX IBM JNJ KO MCD MRK

Jan 3, 2025, 7:39 AM EST - 14 days ago

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

ABBV CVS

Jan 2, 2025, 12:21 PM EST - 15 days ago

January Dow Dogs: 1 'Safer' Buy, And 5 With Promise

BA CRM CSCO CVX DIS GS HD

Jan 2, 2025, 1:01 AM EST - 15 days ago

Amgen stock price formed a death cross: will it rebound in 2025?

Jan 1, 2025, 11:02 PM EST - 15 days ago

Will Dow Jones index 2024 losers become 2025 gainers?

BA NKE

Dec 20, 2024, 2:40 PM EST - 4 weeks ago

What's Going On With Amgen Stock On Friday?

Dec 17, 2024, 9:36 AM EST - 4 weeks ago

PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions Rises

SLXN

Dec 13, 2024, 11:54 PM EST - 4 weeks ago

Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value

AAPL ABBV ABT ACN ADBE ADP AMZN

Dec 10, 2024, 4:30 PM EST - 5 weeks ago

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

Dec 7, 2024, 10:00 AM EST - 5 weeks ago

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Dec 5, 2024, 9:48 AM EST - 6 weeks ago

Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

Dec 5, 2024, 9:17 AM EST - 6 weeks ago

Amgen to invest $1 bln in North Carolina manufacturing site

Dec 5, 2024, 9:00 AM EST - 6 weeks ago

AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA

Dec 4, 2024, 5:37 PM EST - 6 weeks ago

Dow 30 December Dogs Show 28 Pay Dividends And 1 "Safer" Buy

BA CSCO CVX DIS GS IBM JNJ

Dec 4, 2024, 2:27 PM EST - 6 weeks ago

Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

Dec 3, 2024, 9:16 AM EST - 6 weeks ago

Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance

LLY

Dec 3, 2024, 7:30 AM EST - 6 weeks ago

Bargain Hunting In A Pricey Market: 2 High-Yield Dividend Picks That Have Me Hooked

MPLX

Dec 2, 2024, 4:00 PM EST - 6 weeks ago

AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE

Nov 29, 2024, 4:30 PM EST - 7 weeks ago

AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE

Nov 27, 2024, 1:06 PM EST - 7 weeks ago

Amgen's Phase 2 Results Were Not Bad, Don't Let Mr. Market Fool You

Nov 27, 2024, 10:13 AM EST - 7 weeks ago

Where to invest in GLP-1 stocks

LLY NVO

Nov 26, 2024, 6:34 PM EST - 7 weeks ago

Final Trade: JWN, IWM, GCO, AMGN

IWM GCO JWN

Nov 26, 2024, 6:32 PM EST - 7 weeks ago

Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond

Nov 26, 2024, 4:06 PM EST - 7 weeks ago

Stock Market Today: The S&P 500 Reclaims the 6K Level

Nov 26, 2024, 3:03 PM EST - 7 weeks ago

Amgen: MariTide Underwhelms, But There Are Ways To Win

Nov 26, 2024, 2:40 PM EST - 7 weeks ago

Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations

Nov 26, 2024, 1:28 PM EST - 7 weeks ago

The Best Large-Cap Stocks to Buy

ABT BSX CRM GILD GS INTU MDT

Nov 26, 2024, 1:10 PM EST - 7 weeks ago

Chart of the Day: Amgen

Nov 26, 2024, 12:12 PM EST - 7 weeks ago

S&P, Nasdaq climb while Dow dips amid Trump tariff concerns; Amgen, Kohl's shares tumble

KSS

Nov 26, 2024, 10:24 AM EST - 7 weeks ago

Cramer's Stop Trading: Amgen

Nov 26, 2024, 10:09 AM EST - 7 weeks ago

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs

LLY NVO VKTX

Nov 26, 2024, 8:46 AM EST - 7 weeks ago

Amgen's weight-loss injection cuts up to 20% in a year

Nov 26, 2024, 8:36 AM EST - 7 weeks ago

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Nov 26, 2024, 8:32 AM EST - 7 weeks ago

Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.

Nov 26, 2024, 8:05 AM EST - 7 weeks ago

Amgen's stock slides 7.8% after weight-loss drug data lags analyst expectations

Nov 26, 2024, 7:53 AM EST - 7 weeks ago

Amgen says obesity drug caused up to 20% weight loss - after a year, with no plateau

Nov 26, 2024, 7:14 AM EST - 7 weeks ago

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

Nov 26, 2024, 7:10 AM EST - 7 weeks ago

Amgen drug leads to up to 20% weight loss in trial

Nov 26, 2024, 7:05 AM EST - 7 weeks ago

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

Nov 26, 2024, 7:00 AM EST - 7 weeks ago

AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM